Dr Laura Sutton

All publications

Journal articles

• Goodacre S, Thomas B, Lee E, Sutton L, Loban A, Waterhouse S, Simmonds R, Biggs K, Marincowitz C, Schutter J , Connelly S et al (2020) Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study. Emergency Medicine Journal. View this article in WRRO
• Goodacre S, Thomas B, Lee E, Sutton L, Loban A, Waterhouse S, Simmonds R, Biggs K, Marincowitz C, Schutter J , Connelly S et al (2020) Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection : observational cohort study. PLoS ONE, 15(11). View this article in WRRO
• Brown M, Williamson PR, Sutton L, Melling C, Lewis M, Webb NJA & Goyal A (2020) Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children : a pilot randomised controlled trial (OVERT Trial). Journal of Pediatric Urology. View this article in WRRO
• Enderby P & Sutton L (2020) Where are we now with aphasia after stroke?. Annals of Indian Academy of Neurology, 23(8), S57-S62.
• Pine CM, Adair PM, Burnside G, Brennan L, Sutton L, Edwards RT, Ezeofor V, Albadri S, Curnow MM, Deery C , Hosey MT et al (2020) Dental RECUR randomized trial to prevent caries recurrence in children. Journal of Dental Research, 99(2), 168-174. View this article in WRRO
• Hawcutt DB, Ghani AA, Sutton L, Jorgensen A, Zhang E, Murray M, Michael H, Peart I, Smyth RL & Pirmohamed M (2014) Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects. The Pharmacogenomics Journal, 14(6), 542-548.
• Alfirevic A, Carr DF, Miyajima F, Pushpakom S, Sutton L, Jorgensen AL & Pirmohamed M (2013) Institutional Profile: The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK. Pharmacogenomics, 14(8), 861-867.
• Musumba CO, Jorgensen A, Sutton L, Van Eker D, Zhang E, O’Hara N, Carr DF, Pritchard DM & Pirmohamed M (2013) CYP2C19*17 Gain-of-Function Polymorphism Is Associated With Peptic Ulcer Disease. Clinical Pharmacology & Therapeutics, 93(2), 195-203.
• Musumba C, Jorgensen A, Sutton L, Eker D, Moorcroft J, Hopkins M, Pritchard DM & Pirmohamed M (2012) The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Alimentary Pharmacology & Therapeutics, 36(1), 48-56.
• Sutton L, Julious SA & Goodacre SW (2012) Influence of Adaptive Analysis on Unnecessary Patient Recruitment: Reanalysis of the RATPAC Trial. Annals of Emergency Medicine, 60(4), 442-448.e1.
• Goodacre S, Thomas B, Lee E, Sutton L, Biggs K, Marincowitz C, Loban A, Waterhouse S, Simmonds R, Schutter J , Connelly S et al () Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: Observational cohort study. View this article in WRRO

Datasets

• Thomas B, Sutton L, Goodacre S, Biggs K & Loban A PRIEST study anonymised dataset.